Ulcerative Colitis — RACP Adult Medicine MCQ
Instant feedback + full explanation. One question, done properly.
Educational content. Not a substitute for clinical judgement or local policy.
Reveal the answer and explanation
Correct answer: A — Mesalazine 4.8 g daily (oral) plus mesalazine enema
This patient has moderately active left-sided ulcerative colitis. First-line treatment is combined oral and topical (enema) mesalazine at high doses (oral 4–4.8 g/day). Topical therapy is important for left-sided disease. If inadequate response after 2–4 weeks, oral corticosteroids should be added. Budesonide MMX may be considered but standard budesonide has limited colonic activity.
Reference: eTG – 2025 – Gastrointestinal; ECCO – 2022 – UC Guidelines